116 related articles for article (PubMed ID: 38518000)
21. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.
Xiang B; Chen ML; Gao ZQ; Mi T; Shi QL; Dong JJ; Tian XM; Liu F; Wei GH
BMC Med Genomics; 2023 Aug; 16(1):189. PubMed ID: 37592341
[TBL] [Abstract][Full Text] [Related]
22.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
23. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract][Full Text] [Related]
24. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
Yang J; Li H; Hu S; Zhou Y
Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157
[TBL] [Abstract][Full Text] [Related]
25. Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs.
Wu Z; Huang X; Cai M; Huang P
BMC Urol; 2022 Sep; 22(1):152. PubMed ID: 36104680
[TBL] [Abstract][Full Text] [Related]
26. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
[TBL] [Abstract][Full Text] [Related]
27. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
[TBL] [Abstract][Full Text] [Related]
28. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
[TBL] [Abstract][Full Text] [Related]
29. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Lan H; Zeng J; Chen G; Huang H
Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
[TBL] [Abstract][Full Text] [Related]
30. Construction of immune-related risk signature for renal papillary cell carcinoma.
Wang Z; Song Q; Yang Z; Chen J; Shang J; Ju W
Cancer Med; 2019 Jan; 8(1):289-304. PubMed ID: 30516029
[TBL] [Abstract][Full Text] [Related]
31. Insulin-Like Growth Factor Binding Protein 5-A Probable Target of Kidney Renal Papillary Renal Cell Carcinoma.
Wang S; Hong Q; Geng X; Chi K; Cai G; Wu D
Biomed Res Int; 2019; 2019():3210324. PubMed ID: 31886201
[TBL] [Abstract][Full Text] [Related]
32. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
34. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
35. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
Peng W; Li W; Zhang X; Cen W; Liu Y
J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.
Fang L; Liu Q; Cui H; Zheng Y; Wu C
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456460
[TBL] [Abstract][Full Text] [Related]
37. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
Fu H; Li K; Wang S; Li Y
Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
[TBL] [Abstract][Full Text] [Related]
38. Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinoma.
Zhao G; Wang Y; Zhou J; Ma P; Wang S; Li N
Heliyon; 2024 Apr; 10(8):e29373. PubMed ID: 38644836
[TBL] [Abstract][Full Text] [Related]
39. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma.
Yin H; Lin M; Liang S; Wei M; Huang C; Qin F; Nong J; Zeng X; Nong C; Qin H
Front Oncol; 2022; 12():988867. PubMed ID: 36276091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
